Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
Journal
Journal of Viral Hepatitis
Journal Volume
28
Journal Issue
6
Pages
887-896
Date Issued
2021
Abstract
The nephrotoxicity of sofosbuvir (SOF) on human immunodeficiency virus and hepatitis C virus (HIV/HCV)-coinfected patients receiving antiretroviral therapy (ART) remains controversial. We prospectively compared the estimated glomerular filtration rate (eG
SDGs
Other Subjects
bictegravir plus emtricitabine plus tenofovir alafenamide; cobicistat plus elvitegravir plus emtricitabine plus tenofovir alafenamide; daclatasvir; efavirenz plus emtricitabine plus tenofovir disoproxil; emtricitabine plus rilpivirine plus tenofovir alafe
Publisher
Blackwell Publishing Ltd
Type
journal article